The global mast cell tumor treatment market is poised for impressive growth, with forecasts predicting a market valuation of USD 7,836.4 million by 2034. This surge in market size underscores the industry’s upward momentum, bolstered by key drivers such as advancements in diagnostic technologies, rising awareness, and increased focus on early detection. The market is …